This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cardona, C. Articles by Reeve, J. G. Search for Related Content PubMed PubMed Citation Articles by Cardona, C. Articles by Reeve, J. G.

Production of Neuromedin B and Neuromedin B Gene Expression in Human Lung Tumor Cell Lines¹

Medical Research Council, Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Hills Road, Cambridge CB2 2QH, United Kingdom [C. C., J. G. R., P. H. R., N. M. B.]; Oregon Regional Primate Research Center, Beaverton, Oregon 97006 [E. R. S.]; and Department of Medicine, Hammersmith Hospital, Ducane Road, London W12 0HS, United Kingdom [M. A. G., S. R. B.]

Gastrin-releasing peptide (GRP), a mammalian bombesin-like peptide, has been shown to be an important autocrine growth factor for small cell lung cancer (SCLC). However, not all SCLC cell lines express the GRP gene or respond mitogenically to GRP stimulation, suggesting the existence of other autocrine pathways in this tumor. Neuromedin B (NMB), the mammalian counterpart of amphibian ranatensin, has been shown to be a mitogen for SCLC cell lines in vitro. To determine whether NMB is a potential autocrine growth factor for lung tumors, NMB gene expression, peptide synthesis, and secretion have been investigated in a panel of SCLC and non-SCLC (NSCLC) cell lines.

Northern blot analysis and enzymatic amplification from mRNA by polymerase chain reaction showed that the NMB gene was expressed in all SCLC and NSCLC cell lines examined. In contrast, the GRP gene was expressed in four of six classic SCLC cell lines but not in variant SCLC or NSCLC cell lines. Immunoreactive NMB was detected by radioimmunoassay in the majority of classic SCLC, in one of three variant SCLC and in one of three NSCLC cell lines, and secreted NMB was detected in medium conditioned by a SCLC and a NSCLC cell line.

The present study also demonstrated the presence of immunoreactive GRP in the absence of detectable GRP gene expression. The antiserum used in the GRP radioimmunoassay failed to cross-react with NMB but showed some cross-reactivity with amphibian phyllolitorin raising the possibility that certain SCLC cell lines may produce a phyllolitorin-like peptide.

¹ This work was supported in part by NIH Grant CA 39237.

² Recipient of a fellowship from the E. C. Europe Against Cancer program.

³ To whom requests for reprints should be addressed.

Received 4/29/91. Accepted 7/19/91.

This article has been cited by other articles:

				S. Buvinic, M. Bravo-Zehnder, J. L. Boyer, J. P. Huidobro-Toro, and A. Gonzalez Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells J. Cell Sci., December 15, 2007; 120(24): 4289 - 4301. [Abstract] [Full Text] [PDF]

				D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728. [Abstract] [Full Text] [PDF]

				B. E. Johnson, T. Fischer, B. Fischer, D. Dunlop, D. Rischin, S. Silberman, M. O. Kowalski, D. Sayles, S. Dimitrijevic, C. Fletcher, et al. Phase II Study of Imatinib in Patients with Small Cell Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5880 - 5887. [Abstract] [Full Text] [PDF]

				J. M. SIEGFRIED, M. A. A. DEMICHELE, J. D. HUNT, A. G. DAVIS, K. P. VOHRA, and J. M. PILEWSKI Expression of mRNA for Gastrin-Releasing Peptide Receptor by Human Bronchial Epithelial Cells . Association with Prolonged Tobacco Exposure and Responsiveness to Bombesin-like Peptides Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 358 - 366. [Abstract] [Full Text]